reference/31011788

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31011788

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	5587
issn	1557-3265 1078-0432
issueIdentifier	24
pageRange	5578-5587
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	5578
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation	Wang X, Huang Y, Christie A, Bowden M, Lee GS, Kantoff PW, Sweeney CJ. Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity. Clin Cancer Res. 2015 Dec 15;21(24):5578–87. doi: 10.1158/1078-0432.ccr-15-0824. PMID: 26289068.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f40b1c3b6b9a82d05cb52e9515d2bb88 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1145-3606 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70ce4c1f21c4e8950d32970c9aa6db2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd61cf5528ebe5b7a352bb8241b1c10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5efa6dbb38c161d230948b17ec640af8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4375-7823 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c341988e8599008a45820ebade28cd23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6002e261e8e031c07ac7d79c03904737 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_617fd67a3e7b754f8a3917bf5598ea09
date	2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-15-0824 https://pubmed.ncbi.nlm.nih.gov/26289068
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti–Prostate Cancer Activity
discusses	http://id.nlm.nih.gov/mesh/M0328256 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0001214 http://id.nlm.nih.gov/mesh/M0237229 http://id.nlm.nih.gov/mesh/M0026587 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0001114 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0558240
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000813Q000494 http://id.nlm.nih.gov/mesh/D017526Q000378 http://id.nlm.nih.gov/mesh/D000736Q000494 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D011471Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D047368Q000187 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D004336 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020794Q000037 http://id.nlm.nih.gov/mesh/D011471Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25102847 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3da33ba6cc57d9bd47a91ecc7cb7ba07 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132971 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Total number of triples: 67.